Literature DB >> 17017014

Simultaneous analysis of seven astragalosides in Radix Astragali and related preparations by liquid chromatography coupled with electrospray ionization time-of-flight mass spectrometry.

Duo Wang1, Yue Song, Song-Lin Li, Yun-Yun Bian, Jia Guan, Ping Li.   

Abstract

A method has been developed for the qualitative and quantitative analysis of pharmacologically active astragalosides isolated from several species of the genus Astragalus by high performance liquid chromatography coupled with electrospray ionization time-of-flight mass spectrometry. Seven astragalosides in Radix Astragali and their commercial pharmaceutical preparations were analyzed using the developed method. The extracted ion current chromatograms were obtained from the total ion current chromatogram using the m/z of [M+Na]+ ions produced by target compounds for peak determination. The limits of detection and limits of quantification were in the range of 0.10-0.22 ng and 0.22-0.52 ng in full scan mode, respectively. All calibration curves showed good linear regression (r2 > or = 0.9965) within the test range. The overall intra- and inter-day precision was less than 2.86% for peak area and the accuracy was higher than 92.9% on using ginsenoside I as internal standard. The assay was successfully utilized to analyze the major biologically active astragalosides in six samples of Astragalus membranaceus (Fisch.) Bge var. mongholicus (Bge.) Hsiao. and eight commercial preparations. The overall results demonstrate that this method is simple, selective, and suitable for the quality control of Chinese medicine and their preparation in the low nanogram range.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17017014     DOI: 10.1002/jssc.200500486

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  6 in total

1.  Chemical and genetic assessment of variability in commercial Radix Astragali (Astragalus spp.) by ion trap LC-MS and nuclear ribosomal DNA barcoding sequence analyses.

Authors:  Wei-Lie Xiao; Timothy J Motley; Uchenna J Unachukwu; Clara Bik San Lau; Bei Jiang; Feng Hong; Ping-Chung Leung; Qing-Feng Wang; Philip O Livingston; Barrie R Cassileth; Edward J Kennelly
Journal:  J Agric Food Chem       Date:  2011-02-15       Impact factor: 5.279

2.  Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial.

Authors:  Yue-li Sun; Ting Hou; Shu-fen Liu; Zhong-liang Zhang; Ning Zhang; Min Yao; Long Yang; Qi Shi; Xue-jun Cui; Yong-jun Wang
Journal:  Trials       Date:  2015-02-26       Impact factor: 2.279

3.  HPLC-MS/MS analysis of a traditional Chinese medical formulation of Bu-Yang-Huan-Wu-Tang and its pharmacokinetics after oral administration to rats.

Authors:  Lee-Hsin Shaw; Lie-Chwen Lin; Tung-Hu Tsai
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

4.  HPLC-DAD-ELSD Combined Pharmacodynamics and Serum Medicinal Chemistry for Quality Assessment of Huangqi Granule.

Authors:  Huaguo Chen; Xin Zhou; Yang Zhao; Xiao-Jian Gong; Yan He; Feng-Wei Ma; Mei Zhou; Chao Zhao; Yi Niu; Jie Deng
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

5.  A network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney disease.

Authors:  Shao-hua Shi; Yue-piao Cai; Xiao-jun Cai; Xiao-yong Zheng; Dong-sheng Cao; Fa-qing Ye; Zheng Xiang
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

6.  Identification of multiple ingredients for a Traditional Chinese Medicine preparation (bu-yang-huan-wu-tang) by liquid chromatography coupled with tandem mass spectrometry.

Authors:  Lee-Hsin Shaw; Wei-Ming Chen; Tung-Hu Tsai
Journal:  Molecules       Date:  2013-09-12       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.